Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385575581> ?p ?o ?g. }
- W4385575581 endingPage "4117" @default.
- W4385575581 startingPage "4109" @default.
- W4385575581 abstract "Anal cancer is increasing in HIV+ men who have sex with men (MSM). Treatment options for its precursor, high-grade anal intraepithelial neoplasia (HGAIN), are suboptimal. In this phase I to II dose-finding study, we assessed the safety and efficacy of the human papillomavirus type 16 (HPV16) synthetic long peptide vaccine (SLP-HPV-01) in HIV+ MSM with HPV16-positive HGAIN.Four dosage schedules (1-5-10; 5-10-20; 10-20-40; and 40-40-40-40 μg) of SLP-HPV-01 were administered intradermally with a 3-week interval in 10 patients per dose level (DL). In each dose group, 5 patients also received 1 μg/kg pegylated IFNα-2b subcutaneously. Primary endpoints were safety and regression of HGAIN at 3, 6, and 12 months.Eighty-one of 134 screened patients (60%) had HPV16-negative HGAIN lesions, leaving 53 eligible patients. Thirteen patients were excluded, leaving 40 men. The vaccine was well tolerated. One patient developed a generalized rash. The highest dosage level induced the strongest immune responses. There was no indication for stronger reactivity in the IFNα groups. Up to 18 months of follow-up, 8/38 intention-to-treat patients had a complete clinical and histologic response and one had a partial response (in total 9/38, 23.7%). At the highest dosage level, the clinical response was 4/10 (40%). Stronger immune responses were detected among clinical responders.The highest DL is safe, immunogenic, and associated with clinical responses to HPV16-induced lesions. However, as the majority of HGAIN is caused by the other HPV types, further studies should aim at pan-HPV vaccination to prevent or treat HGAIN." @default.
- W4385575581 created "2023-08-05" @default.
- W4385575581 creator A5015546063 @default.
- W4385575581 creator A5017577408 @default.
- W4385575581 creator A5020869847 @default.
- W4385575581 creator A5031418806 @default.
- W4385575581 creator A5035565968 @default.
- W4385575581 creator A5039123720 @default.
- W4385575581 creator A5041281028 @default.
- W4385575581 creator A5059027820 @default.
- W4385575581 creator A5060053979 @default.
- W4385575581 creator A5068299772 @default.
- W4385575581 creator A5069267169 @default.
- W4385575581 creator A5082771064 @default.
- W4385575581 creator A5092596791 @default.
- W4385575581 date "2023-08-04" @default.
- W4385575581 modified "2023-10-15" @default.
- W4385575581 title "Therapeutic Vaccination against Human Papillomavirus Type 16 for the Treatment of High-Grade Anal Intraepithelial Neoplasia in HIV+ Men" @default.
- W4385575581 cites W1495439468 @default.
- W4385575581 cites W1688526230 @default.
- W4385575581 cites W1965416300 @default.
- W4385575581 cites W1990555336 @default.
- W4385575581 cites W1995464861 @default.
- W4385575581 cites W2011898088 @default.
- W4385575581 cites W2014985358 @default.
- W4385575581 cites W2023414073 @default.
- W4385575581 cites W2067757218 @default.
- W4385575581 cites W2067818215 @default.
- W4385575581 cites W2084523111 @default.
- W4385575581 cites W2089115481 @default.
- W4385575581 cites W2093150743 @default.
- W4385575581 cites W2096866753 @default.
- W4385575581 cites W2102143045 @default.
- W4385575581 cites W2106115615 @default.
- W4385575581 cites W2111636713 @default.
- W4385575581 cites W2120270602 @default.
- W4385575581 cites W2124385271 @default.
- W4385575581 cites W2131550376 @default.
- W4385575581 cites W2153992214 @default.
- W4385575581 cites W2165649863 @default.
- W4385575581 cites W2168733003 @default.
- W4385575581 cites W2272228147 @default.
- W4385575581 cites W2286765507 @default.
- W4385575581 cites W2317464501 @default.
- W4385575581 cites W2734541651 @default.
- W4385575581 cites W2769206492 @default.
- W4385575581 cites W2884002019 @default.
- W4385575581 cites W2892876553 @default.
- W4385575581 cites W2903493397 @default.
- W4385575581 cites W3012160408 @default.
- W4385575581 cites W3012223268 @default.
- W4385575581 cites W3020192474 @default.
- W4385575581 cites W3163153879 @default.
- W4385575581 cites W3189139814 @default.
- W4385575581 cites W4282974371 @default.
- W4385575581 doi "https://doi.org/10.1158/1078-0432.ccr-22-3361" @default.
- W4385575581 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37540563" @default.
- W4385575581 hasPublicationYear "2023" @default.
- W4385575581 type Work @default.
- W4385575581 citedByCount "0" @default.
- W4385575581 crossrefType "journal-article" @default.
- W4385575581 hasAuthorship W4385575581A5015546063 @default.
- W4385575581 hasAuthorship W4385575581A5017577408 @default.
- W4385575581 hasAuthorship W4385575581A5020869847 @default.
- W4385575581 hasAuthorship W4385575581A5031418806 @default.
- W4385575581 hasAuthorship W4385575581A5035565968 @default.
- W4385575581 hasAuthorship W4385575581A5039123720 @default.
- W4385575581 hasAuthorship W4385575581A5041281028 @default.
- W4385575581 hasAuthorship W4385575581A5059027820 @default.
- W4385575581 hasAuthorship W4385575581A5060053979 @default.
- W4385575581 hasAuthorship W4385575581A5068299772 @default.
- W4385575581 hasAuthorship W4385575581A5069267169 @default.
- W4385575581 hasAuthorship W4385575581A5082771064 @default.
- W4385575581 hasAuthorship W4385575581A5092596791 @default.
- W4385575581 hasConcept C121608353 @default.
- W4385575581 hasConcept C126322002 @default.
- W4385575581 hasConcept C197934379 @default.
- W4385575581 hasConcept C203014093 @default.
- W4385575581 hasConcept C22070199 @default.
- W4385575581 hasConcept C2778570526 @default.
- W4385575581 hasConcept C2779840525 @default.
- W4385575581 hasConcept C44249647 @default.
- W4385575581 hasConcept C71924100 @default.
- W4385575581 hasConcept C8891405 @default.
- W4385575581 hasConcept C90924648 @default.
- W4385575581 hasConceptScore W4385575581C121608353 @default.
- W4385575581 hasConceptScore W4385575581C126322002 @default.
- W4385575581 hasConceptScore W4385575581C197934379 @default.
- W4385575581 hasConceptScore W4385575581C203014093 @default.
- W4385575581 hasConceptScore W4385575581C22070199 @default.
- W4385575581 hasConceptScore W4385575581C2778570526 @default.
- W4385575581 hasConceptScore W4385575581C2779840525 @default.
- W4385575581 hasConceptScore W4385575581C44249647 @default.
- W4385575581 hasConceptScore W4385575581C71924100 @default.
- W4385575581 hasConceptScore W4385575581C8891405 @default.
- W4385575581 hasConceptScore W4385575581C90924648 @default.
- W4385575581 hasIssue "20" @default.
- W4385575581 hasLocation W43855755811 @default.